The Treatment of Lung Involvement in Systemic Sclerosis

Systemic sclerosis (SSc) patients are often affected by interstitial lung disease (ILD) and, although there have been recent treatment advances, it remains the leading cause of death among SSc, with a 10-year mortality up to 40%. African Americans and subjects with diffuse cutaneous SSc or anti-topo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruaro, Barbara, Confalonieri, Marco, Matucci-Cerinic, Marco, Salton, Francesco, Confalonieri, Paola, Santagiuliana, Mario, Citton, Gloria Maria, Baratella, Elisa, Bruni, Cosimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918752/
https://www.ncbi.nlm.nih.gov/pubmed/33668530
http://dx.doi.org/10.3390/ph14020154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918752/
https://www.ncbi.nlm.nih.gov/pubmed/33668530
http://dx.doi.org/10.3390/ph14020154

Ejemplares similares